SCHEMBL12901006

SCHEMBL12901006

O=C(NCCc1ccncc1)c1sccc1Nc1ccnc2[nH]ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
NEK1 Q96PY6 1/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 2/20 0.39
HIF1A Q16665 2/20 0.39
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TYK2 P29597 1/20 0.38
ALDH1A1 P00352 2/20 0.38
KDR P35968 1/20 0.37
AKT1 P31749 2/20 0.37
TGFBR1 P36897 1/20 0.36
AKT2 P31751 1/20 0.36
ROCK2 O75116 2/20 0.36
CIT O14578 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19390620 0.92 RAB9A (0.43) NEK1RAB9ASMN1; SMN2NPC1HIF1A
SCHEMBL12900374 0.90 AKT1 (0.39) HDAC6NEK1RAB9ASMN1; SMN2NPC1
SCHEMBL12901013 0.90 NPC1 (0.43) NEK1RAB9ASMN1; SMN2NPC1JAK2
SCHEMBL19390444 0.90 MAPT (0.46) NEK1RAB9ASMN1; SMN2NPC1JAK2
SCHEMBL12901738 0.89 KDR (0.40) NEK1SMN1; SMN2JAK2JAK1TYK2
SCHEMBL12900697 0.89 HDAC2 (0.42) HDAC2HDAC8HDAC6NEK1RAB9A
SCHEMBL12900377 0.89 KMT2A (0.45) SMN1; SMN2ALDH1A1CITLMNAMAPT
SCHEMBL12901033 0.87 NPC1 (0.45) NEK1RAB9ASMN1; SMN2NPC1JAK2
SCHEMBL16687548 0.87 KMT2A (0.48) ALDH1A1
SCHEMBL12901040 0.85 AKT1 (0.50) NEK1JAK2JAK1TYK2AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462141-B1 NOVEL AZAHETEROCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2017-09-27 EP disclosed
US-9023847-B2 Azaheterocyclic compounds MERCK PATENT GMBH (DE) 2015-05-05 US disclosed
US-20120277228-A1 Novel Azaheterocyclic Compounds MERCK PATENT GMBH (DE) 2012-11-01 US disclosed
WO-2011017009-A1 NOVEL AZAHETEROCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2011-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277228-A1 Novel Azaheterocyclic Compounds PCNA, MCL1, MYC HDAC2 1111/4885HDAC8 764/4885HDAC6 688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.